Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone

Pediatrics International

Volumn 49, Issue 5, 2007, Pages 659-662

  Aihara, Yukoh ^a   Ito, Reiko ^a   Ito, Shuichi ^a   Aihara, Michiko ^a   Yokota, Shumpei ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cyclosporin A; G CSF; Leukopenia; Methylprednisolone; Toxic epidermal necrolysis

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PABURON; PARACETAMOL; PREDNISOLONE; ULINASTATIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; DRUG MEGADOSE; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; SCHOOL CHILD; THERAPY EFFECT; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; VESICULAR RASH;

CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; METHYLPREDNISOLONE; TREATMENT OUTCOME;

EID: 34548690795     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02439.x     Document Type: Article

References (14)

1. Garcia-Doval I, LeCleach L, Boucquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch. Dermatol. 2000 136 : 323 27.
2. Becker DS. Toxic epidermal necrolysis. Lancet 1998 351 : 1417 20.
3. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998 282 : 490 93.
4. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch. Dermatol. 1993 129 : 92 6.
5. Patterson R, Miller M, Kaplan M et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: Experience with 41 cases and a hypothesis regarding pathogenesis. Ann. Allergy 1994 73 : 27 34.
6. Wolkenstein P, Latarjet J, Roujeau JC et al. Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998 352 : 1586 9.
7. Aihara Y, Ito S, Kobayashi Y, Aihara M. Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy 2004 59 : 118.
8. Aihara M, Mitani N, Kakemizu N et al. Human herpesvirus infection in drug-induced hypersensitivity syndrome, toxic epidermal necrolysis and Stevens-Johnson syndrome. Allergol. Int. 2004 53 : 23 9.
9. Leyva L, Torres MJ, Posadas S et al. Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response. J. Allergy Clin. Immunol. 2000 105 : 157 65.
10. Inamo Y, Okubo T, Wada M et al. Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients. Int. Arch. Allergy Immunol. 2002 127 : 89 94.
11. Paquet P, Pierard GE. Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatology 1999 198 : 198 202.
12. Arevalo JM, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporin A. J. Trauma 2000 48 : 473 8.
13. Renfro L, Grant-Kels JM, Daman LA. Drug-induced toxic epidermal necrolysis treated with cyclosporin. Int. J. Dermatol. 1989 28 : 441 4.
14. Jarrett P, Rademaker M, Havill J, Pullon H. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor. Clin. Exp. Dermatol. 1997 22 : 146 7.